Anaptysbio, inc (ANAB)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss) Attributable to Parent

-83,520

-97,336

-94,067

-78,992

-68,648

-61,656

-51,523

-44,655

-33,721

-30,070

-27,787

-19,812

-14,806

-4,259

0

0

0

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

539

514

480

436

376

315

256

211

198

183

194

206

215

233

0

0

0

Stock-based compensation

12,519

12,411

12,275

11,663

10,568

9,961

8,472

6,882

5,772

4,378

3,534

2,847

1,704

1,160

0

0

0

Fair Value Adjustment of Warrants

-

-

-

-

-

-

-

-

-

1,366

2,457

2,504

2,501

756

0

0

0

Accretion/amortization of investments, net

1,613

2,633

3,127

2,904

2,178

1,233

0

0

0

-

-

-

-

-

-

-

-

(Income) loss from investments

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

Non-cash interest expense

-512

-676

-668

-661

-654

-646

-640

-633

-625

-619

-485

-358

-233

-105

0

0

0

Income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-139

0

0

0

Changes in operating assets and liabilities:
Receivable from collaborative partners

5,000

0

0

0

0

-

-

-

-

-1,225

-860

-980

-1,191

-1

0

0

0

Australian tax incentive receivable

-

-

-

-

-

-1,427

-1,313

-5,485

-3,355

-2,517

-1,807

3,039

4,965

4,118

0

0

0

Prepaid expenses and other assets

-3,626

-2,178

1,860

2,567

6,791

5,188

1,707

581

1,354

1,885

2,149

3,197

906

1,079

0

0

0

Accounts payable and other liabilities

4,233

14,499

14,317

17,646

12,317

7,083

7,083

2,215

1,378

2,218

1,913

2,652

3,026

1,251

0

0

0

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,942

0

0

0

Net cash used in operating activities

-68,530

-69,517

-66,002

-58,766

-52,127

-48,506

-41,026

-30,054

-23,819

-19,438

-20,198

-19,383

-15,071

-9,030

0

0

0

CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of investments

246,065

251,815

398,591

389,439

395,097

347,537

304,199

291,963

296,108

290,905

110,701

89,353

27,000

0

0

0

0

Sales and maturities of investments

379,302

384,051

360,744

316,385

261,168

206,149

175,822

138,168

82,718

48,137

0

0

0

-

-

-

-

Purchases of property and equipment

712

805

907

948

1,011

1,063

981

673

437

290

167

154

100

50

0

0

0

Net cash provided by investing activities

132,525

131,431

-38,754

-74,002

-134,940

-142,451

-129,358

-154,468

-213,827

-243,058

-90,002

-89,507

-27,100

-50

0

0

0

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from Issuance of Common Stock

-

-

-

-

-

-

-

-

-

292,537

80,213

80,213

80,213

0

0

0

0

Proceeds from issuance of common stock, upon the exercise of stock options

2,462

3,000

1,974

2,189

3,371

2,869

2,303

1,945

696

979

829

525

377

31

0

0

0

Proceeds from issuance of common stock, upon the exercise of warrants

-

-

-

-

-

76

76

77

76

536

536

535

535

0

0

0

0

Payments on notes payable

7,000

7,500

7,500

7,500

7,500

6,875

5,000

3,125

1,250

0

0

0

0

-

-

-

-

Payments for repurchase of common stock

-

-

-

-

-

-

-

-

-

-

-

-

-

1

0

0

0

Payments for offering costs, net

-

-

-

-

-

-

-

0

0

-

-

1,962

1,263

1,147

0

0

0

Net cash used in financing activities

-4,531

-4,493

-5,754

222,263

223,446

223,364

437,123

210,827

210,366

292,453

89,735

89,056

89,607

8,628

0

0

0

Net decrease in cash, cash equivalents, and restricted cash

59,464

57,421

-110,510

89,495

36,379

32,407

266,739

26,305

-27,280

29,957

-20,465

-19,834

47,436

-452

0

0

0

SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid

256

424

592

759

918

1,043

1,162

1,205

1,108

1,089

855

649

545

354

0

0

0

Non-cash investing and financing activities:
Amounts accrued for property and equipment

-106

41

81

-21

385

159

339

376

146

191

116

113

149

104

0

0

0

Amounts accrued for offering costs

-

-

-

-

-

-

-

-

-

-

-

-

1,879

849

0

0

0

Reclassification of warrants to equity

-

-

-

-

-

-

-

-

-

4,607

4,607

4,607

4,607

0

0

0

0